Mergers & Acquisitions ·
Aurora Cannabis urges shareholders to reject Curaleaf's revised hostile bid
ACBAurora Cannabis Inc
Aurora Cannabis reaffirms its Board recommendation that shareholders reject the revised hostile takeover offer from Curaleaf Holdings, Inc. The company argues the bid significantly undervalues Aurora and fails to address concerns regarding funding mechanisms and risk allocation. Aurora's Special Committee is actively exploring strategic alternatives, including potential transactions with third parties or remaining independent, to maximize shareholder value. Shareholders are advised to take no action and wait for further developments before December 4, 2026. Aurora operates in the global medical cannabis industry.